Medical Devices: Benefits of Strategic Partnerships in the USA
Panel Discussion with Maurice Ben-Mayor, Stryker South Pacific; Kathy O'Connell, Johnson and Johnson Innovation; Pat Williams, Edwards Lifesciences Pty Ltd; and Andrew Wiltshire, Medtronic ANZ. Moderated by Ben McLaughlin, Baker McKenzie
AmCham and the Australian Department of Innovation Industry and Science Entrepreneurs’ Programme invite you to hear from key industry experts to discuss the terms of engagement in the USA and the joint-venture models for R&D, Manufacturing and Distributing.
If you operate an Australian business looking to expand into the U.S. market place, this is an ideal opportunity to learn how partnerships can work quickly and efficiently.
For expressions of interest, please contact Amie O'Mahony, Government Relations Manager via email at [email protected] or on 02 8031 9000.
About the Panellists
Maurice Ben-Mayor, President, Stryker South Pacific
Maurice Ben-Mayor has more than 20 years of experience in the Medical Technology sector. He is president for Stryker South Pacific, a position he has held since 2015. Prior to this, Maurice spent seven years serving in a number of director roles within Stryker’s sales and marketing divisions. Maurice originally joined Stryker as a marketing manager in 2003. Prior to Stryker, Maurice worked as a sales representative for medical devices company, Synthes. Maurice is passionate about innovative technology, developing people and building high-performing cultures. Maurice holds a Bachelor of Science (Psychology) and an MBA, both from The University of New South Wales. He is also a current board member of the Medical Technology Association of Australia.
Kathy Connell, Senior Director New Ventures ANZ, Johnson and Johnson Innovation
Kathy
Connell has a clinical, academic, commercial and legal background with more
than 25 years cross-sector experience including in the pharmaceutical, medtech,
biotechnology, academia and hospital industries. Today she is responsible for
implementing Johnson and Johnson Innovation’s external partnerships and growth
strategy across Australia and NZ for pharmaceuticals, medical device and
consumer health. Kathy’s remit is to identify, assess and establish early stage
collaborative research, licensing and investment opportunities to support Johnson &
Johnson’s global R&D pipelines. Passionate about encouraging and building global
collaborations to deliver new and disruptive healthcare solutions, Kathy works
closely with university, government, venture capital and industry stakeholders
to identify novel ways of engaging with innovation communities to help drive
and build bio-economies across Australia and NZ. These activities are
undertaken with the joint objectives to develop sustainable and long-term
sources of healthcare innovations and deliver healthcare solutions to patients
globally.
Pat Williams, Managing Director ANZ, Edwards Lifesciences Pty Ltd
Patrick Williams, MB Marketing Management, is managing director, Australia and New Zealand, Edwards Lifesciences. Prior to his current role, Williams was responsible for the Critical Care ANZ business. Before joining Edwards Lifesciences, Williams has served in a number of roles in Medtronic. He was a business director Cardiovascular (2008-2011), business manager – ENT & Neuro Technologies (2004-2008), business manager ENT (2000-2004) and product manager (1996-2000). Prior to that, Williams was a Sales Rep with American Cyanamid. Williams received a diploma in Education and Teaching from Catholic College Education in Sydney, and a master’s degree in business major in Marketing/Marketing Management, General from University of Technology Sydney.
Andrew Wiltshire, Senior Director Corporate Affairs, Medtronic ANZ
Andrew’s Career with Medtronic spans 19 years. For the past four years in his current role Andrew has had responsibility for a range of functions including; Government Affairs, Healthcare Economics and Reimbursement, Quality, Regulatory Affairs, Corporate Communications and Public Affairs in Australia and New Zealand. In addition Andrew represents the Asia region on the Medtronic Global Regulatory Council.
Previously Andrew spent three years as General Manager Medtronic Neuromodulation ANZ. Other roles include; Vitatron Business Manager ANZ, CRDM Education and Training Manager ANZ, and Queensland CRDM/CV Territory Manager. Prior to joining Medtronic Andrew worked in a sales role with Bristol Myers-Squibb Pharmaceuticals, and has also worked in a human resources management role in the hospitality Industry, and as a Registered Nurse.
Andrew originally trained and worked as a Registered Nurse and subsequently gained a Bachelor of Arts in Media Studies and Media Production and holds a Masters of Business Administration majoring in Marketing and Human Resource Management. Andrew is a Director of Medtronic Australasia Pty Ltd, Medtronic New Zealand Ltd and the Medical Technology Association of Australia.
For expressions of interest, please contact Amie O'Mahony, Government Relations Manager via email at [email protected] or on 02 8031 9000.
Event Partner
Event Host